Click chemistry-driven modular radionuclide labeling of HER2 nanobody: An integrated platform for diagnosis and treatment of precision oncology
Authors:
- 26 June 2026
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 317, 119104
Abstract
No abstract availableKeywords
Funding Information
- Shenzhen Science and Technology Innovation Program (JCYJ20220818101804009)
- National Natural Science Foundation of China (82102115)
- National Natural Science Foundation of China (82373212)
This publication has 38 references indexed in Scilit:
- Efficacy of radiolabelled PD-L1-targeted nanobody in predicting and evaluating the combined immunotherapy and chemotherapy for resectable non-small cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2025
- ImmunoPET imaging of Trop2 expression in solid tumors with nanobody tracersEuropean Journal of Nuclear Medicine and Molecular Imaging, 2023
- High in-vivo stability in preclinical and first-in-human experiments with [18F]AlF-RESCA-MIRC213: a 18F-labeled nanobody as PET radiotracer for diagnosis of HER2-positive cancersEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- VHH characterization. Comparison of recombinant with chemically synthesized anti‐HER2 VHHProtein Science, 2019
- Nanobody: outstanding features for diagnostic and therapeutic applicationsAnalytical and Bioanalytical Chemistry, 2019
- Click Reaction: An Applicable Radiolabeling Method for Molecular ImagingNuclear Medicine and Molecular Imaging, 2015
- A biparatopic anti‐EGFR nanobody efficiently inhibits solid tumour growthInternational Journal of Cancer, 2011
- Fast and Sensitive Pretargeted Labeling of Cancer Cells through a Tetrazine/trans‐Cyclooctene CycloadditionAngewandte Chemie International Edition, 2009
- Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotateEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginineEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003